Guangzhou Biotechnology Investment Fund
Overview
Guangzhou Biotechnology Investment Fund (GIBF) is a private equity firm that focuses on venture opportunities in the healthcare and life sciences industries, often partnering with overseas companies to establish joint ventures in the Chinese market.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CoreBone | Oct 2021 | Series A | Lead |
| 心医国际数字医疗系统（大连）有限公司 | Sep 2014 | Series B | Co-investor |
| CarboFix Orthopedics | Mar 2011 | Seed | Co-investor |
Key People
Shailesh More
Co-Founder and Chief Operating Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Guangzhou Biotechnology Investment Fund based?
Guangzhou Biotechnology Investment Fund is headquartered in Guangzhou, China.
When was Guangzhou Biotechnology Investment Fund founded?
Guangzhou Biotechnology Investment Fund was founded in 2016.
How many portfolio companies does Guangzhou Biotechnology Investment Fund have?
Guangzhou Biotechnology Investment Fund has 3 portfolio companies in Caplight's dataset.
What are some companies in Guangzhou Biotechnology Investment Fund's portfolio?
Recent investments visible on Caplight include CoreBone, 心医国际数字医疗系统（大连）有限公司, CarboFix Orthopedics.
What was Guangzhou Biotechnology Investment Fund's most recent investment?
Guangzhou Biotechnology Investment Fund's most recent investment on Caplight was in CoreBone in 2021.
What sectors does Guangzhou Biotechnology Investment Fund focus on?
Guangzhou Biotechnology Investment Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Guangzhou Biotechnology Investment Fund focus on?
Guangzhou Biotechnology Investment Fund typically invests at the Early stage.
What is Guangzhou Biotechnology Investment Fund's AUM?
Guangzhou Biotechnology Investment Fund's assets under management are estimated between $334.2M and $362.0M.